Neisseria meningitidis lipopolysaccharides in human pathology.
about
Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathyDifferential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis.Cellular and molecular biology of Neisseria meningitidis colonization and invasive diseaseGene expression results in lipopolysaccharide-stimulated monocytes depend significantly on the choice of reference genes.Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemiaUnusual genetic organization of a functional type I protein secretion system in Neisseria meningitidis.Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life.The sweet tooth of bacteria: common themes in bacterial glycoconjugates.Prevalence and clinical course in invasive infections with meningococcal endotoxin variants.Differential role of lipooligosaccharide of Neisseria meningitidis in virulence and inflammatory response during respiratory infection in mice.Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitidisAgonists of Toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B.Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains.A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia.Sequential analysis of biomarkers in cerebrospinal fluid and serum during invasive meningococcal disease.Inflammatory response of Haemophilus influenzae biotype aegyptius causing Brazilian Purpuric Fever.Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B.Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide.Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease.Lack of lipid A pyrophosphorylation and functional lptA reduces inflammation by Neisseria commensalsGlobal effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes.MyD88-dependent signaling affects the development of meningococcal sepsis by nonlipooligosaccharide ligandsHuman lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria.Transcriptomic data from two primary cell models stimulating human monocytes suggest inhibition of oxidative phosphorylation and mitochondrial function by N. meningitidis which is partially up-regulated by IL-10.Large-scale reduction of tyrosine kinase activities in human monocytes stimulated in vitro with N. meningitidis.
P2860
Q28475336-ACE3C652-42D7-416F-BAE1-E955A7B2588FQ33438433-247CE8F4-7E47-4AE9-8641-AF4EEDA589B6Q33696949-76D12659-EA8F-4474-B87D-60B00BC68309Q33908019-2943DDB6-41E7-45DA-BA24-06DEEFA9FF1BQ33997331-E6219072-DDA0-4FF4-9916-08A87A0AA51DQ34034177-6CDF9EC5-4056-4B1C-A11C-C486412412C7Q34260635-55436D14-33AC-48BB-99A5-24ECABDCB724Q34297837-0EBE3E79-E408-45A4-B9D9-B2CE46CC88E0Q34499619-7F1BF832-4548-40F4-A615-2773E282548AQ35073946-E52CBD7B-34E1-49D1-BF54-2A891484EA0EQ35273041-D4DD13CB-F6AB-4D2C-8528-82948D034C2FQ36045357-DCF981A5-1170-47EF-89B7-714D95F9B632Q36313996-09928EA8-F21C-4A8E-B3F5-612D01B228E4Q36710627-07703D50-01AA-4EA3-A290-E6483BE4E7A4Q36747169-952EF84C-D6E5-4650-B722-196973AFBED8Q37220979-10553948-5E58-4C17-A0D5-0F38A62B200AQ39039332-D337D82F-160F-4207-876D-13A9F430FF32Q40179618-086057F7-417E-4622-BBE0-6B2C438236B5Q40384654-B3E74AD6-7021-4849-8A8D-A9AAFE1B460BQ40883151-8ED99D52-B5BB-4912-8176-43C340E67F7FQ41039806-24072075-0773-47C5-A74B-72504CAB3270Q41584736-862FAC7C-DA1E-405B-8AAD-2678FEA45740Q41584966-74A4C40C-70B5-41F7-842E-5182944C31CAQ42259008-81EF6233-45E5-4E3A-B7CB-0C8235DCCAF1Q44750380-611356B3-8F4A-441B-9815-D1E3FD97AE48Q47169613-CEEA4316-018C-41CD-B6F7-7906EF4DEA6AQ48193297-EF7C095B-A365-4A16-A0FA-FC8EF32A2D79
P2860
Neisseria meningitidis lipopolysaccharides in human pathology.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neisseria meningitidis lipopolysaccharides in human pathology.
@ast
Neisseria meningitidis lipopolysaccharides in human pathology.
@en
Neisseria meningitidis lipopolysaccharides in human pathology.
@nl
type
label
Neisseria meningitidis lipopolysaccharides in human pathology.
@ast
Neisseria meningitidis lipopolysaccharides in human pathology.
@en
Neisseria meningitidis lipopolysaccharides in human pathology.
@nl
prefLabel
Neisseria meningitidis lipopolysaccharides in human pathology.
@ast
Neisseria meningitidis lipopolysaccharides in human pathology.
@en
Neisseria meningitidis lipopolysaccharides in human pathology.
@nl
P2093
P921
P1476
Neisseria meningitidis lipopolysaccharides in human pathology.
@en
P2093
P304
P356
10.1179/096805101101533016
P577
2001-01-01T00:00:00Z